Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding

NCT01821326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 339

Last updated 2017-01-25

Study results available
· View outcomes & findings →

Summary

The investigators investigated the rebleeding rate the risk factors for rebleeding after long-term follow-up (≥12 months) in patients who underwent capsule endoscopy for obscure gastrointestinal bleeding.

Conditions

  • Gastrointestinal Bleeding

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Zhizheng Ge, M.D. PhD. · RenJi Hospital

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2013-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01821326 on ClinicalTrials.gov